(Q33595339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

S E Dahlén

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

Journal of Internal Medicine

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

205-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10205583%20AND%20SRC:MED&resulttype=core&format=json

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The growing phospholipase A2 superfamily of signal transduction enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Colocalization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Function and inhibition of intracellular calcium-independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Pancreatic islets express a Ca2+-independent phospholipase A2 enzyme that contains a repeated structural motif homologous to the integral membrane protein binding domain of ankyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Characterization of the human 5-lipoxygenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Characterization of the human 5-lipoxygenase gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Cloning of the guinea pig 5-lipoxygenase gene and nucleotide sequence of its promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene A4 hydrolase is a zinc-containing aminopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene A4 hydrolase in the human B-lymphocytic cell line Raji: indications of catalytically divergent forms of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Cloning and characterization of the human leukotriene A4 hydrolase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Solubilization and characterization of the leukotriene C4 synthetase of rat basophil leukemia cells: A novel, participate glutathione S-transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Isolation and characterization of leukotriene C4 synthetase of rat basophilic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione S-transferase composed of 18-kDa subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Molecular cloning and expression of human leukotriene-C4 synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Identification and characterization of a novel human microsomal glutathione S-transferase with leukotriene C4 synthase activity and significant sequence identity to 5-lipoxygenase-activating protein and leukotriene C4 synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Molecular Cloning of the Gene for Human Leukotriene C Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Rapid import of cytosolic 5-lipoxygenase into the nucleus of neutrophils after in vivo recruitment and in vitro adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Human B lymphocytes possess 5-lipoxygenase activity and convert arachidonic acid to leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

On the expression and regulation of 5-lipoxygenase in human lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effects of monocyte-lymphocyte interaction on the synthesis of leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Identification of the biosynthetic leukotriene C4 export pump in murine mastocytoma cells as a homolog of the multidrug-resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Reconstitution of ATP-dependent leukotriene C4 transport by Co-expression of both half-molecules of human multidrug resistance protein in insect cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effects of 1-chloro-2,4,6-trinitrobenzene on 5-lipoxygenase activity and cellular leukotriene synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene B4 in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Evidence for a mediator role of thromboxane A2 in the myotropic action of leukotriene B4 (LTB4) on the guinea-pig lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Mechanisms of leukotriene-induced contractions of guinea pig airways: Leukotriene C4has a potent direct action whereas leukotriene B4acts indirectly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene B4 binding to human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Activation of leukocyte movement and displacement of [3H]leukotriene B4 from leukocyte membrane preparations by (12R)- and (12S)-hydroxyeicosatetraenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Cloning of cDNA encoding a putative chemoattractant receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Biological profile of leukotrienes C4 and D4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Contractile activities of structural analogs of leukotrienes C and D: necessity of a hydrophobic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Contractile activities of structural analogs of leukotrienes C and D: role of the polar substituents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Evidence for two leukotriene receptor types in the guinea-pig isolated ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The effect of leukotriene C4 on mucin release into the cat trachea in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Asthmatic airways have a disproportionate hyperresponsiveness to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Regulation of prostaglandin formation by glucocorticoids and their second messenger, lipocortins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Inhibition of eicosanoid biosynthesis by glucocorticoids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Differential regulation of cyclo-oxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: its repeatability, absence of a late-phase reaction, and the role of histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Worldwide clinical experience with the first marketed leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Intolerance to aspirin. Clinical studies and consideration of its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Role of cytosolic phospholipase A2 in allergic response and parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Identification and isolation of a membrane protein necessary for leukotriene production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00418.X